Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Recursion Pharmaceuticals Inc insiders reported 3 transactions totaling $430,930.56. Activity included 2 tax payments ($333,430.56) and 1 sale ($97,500.00) in August 2026. View more Major Holders ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results